Research Partnership welcomes Jeanne Penn
We are delighted to announce that Jeanne Penn has joined the Singapore office as a Senior Research Executive.
Jeanne previously worked at Cello Health Insight in New York City on the qualitative team, where she was involved in all parts of the research process, from writing proposals to delivering reports. She’s worked in various therapy areas, and has a particular interest in rare diseases and mental health. In a prior role, she co-led the first Diversity & Inclusion initiative and was awarded the Young Professionals Grant to attend the Qualitative Research Consultants Association (QRCA) conference. Jeanne graduated from Hamilton College, and interned at Hall & Partners where she was first introduced to healthcare market research.
How we uncovered unmet needs using social media listening
Our client wanted to further their understanding of the impacts a long-term rare skin condition can have on patients by exploring the patient journey. Market research was required to identify opportunities for improving the patient experience and inform the brand strategy for their product.
The timely tracking of a global launch
Managing ATUs with staggered launches across multiple markets can be tricky. Research Director Rebecca Davies outlines how we approach the challenge.
A key challenge faced by our clients running global tracking studies is when to track. For a product yet to launch, commercialisation can vary by market by months or years. Typically, data is collected at 3 key stages - a time point prior to launch, a couple of months post launch and then at regular intervals. This issue is - how can ATU projects be managed when a product is due to be commercialised at different time points across markets?
Top 10 tips for conducting effective UX research
Creating a new digital asset? Make sure you do your research first. Different stakeholders, whether they are healthcare professionals, consumers, patients or caregivers, exhibit different behaviours and needs online. Ensure your asset offers the optimum user experience by following our 10 top tips for conducting effective UX research
Therapy Watch launches a new Migraine tracker
This multi country study will report on patients with Migraine prophylaxis. The new class of CGRP inhibitors (Aimovig, Ajovy, and Emgality) look set to shake up the migraine prophylaxis market, a market which has seen little innovation in the last decade and in which there still remains considerable unmet patient need.